- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 14, 2025 | 291.56M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $5.94M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $5.16M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $999.83K |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $2.27M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.03M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $2.36M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $6.49M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $5.45M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $6.7M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $5.78M |
| Capex | Q3 2025 · Dec 31, 2023 | $92.69K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | $3.44M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $3.26M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $3.02M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $1.81M |
| Eps Diluted restated | Q3 2025 · Dec 31, 2023 | $0.00 |
| Eps Diluted restated | Q3 2025 · Dec 31, 2023 | $0.01 |
| Eps Basic restated | Q3 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic restated | Q3 2025 · Dec 31, 2023 | $0.01 |
| Net Income | Q3 2025 · Dec 31, 2023 | $192.14K |
| Net Income | Q3 2025 · Dec 31, 2023 | $1.4M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $202.67K |
| Operating Income | Q3 2025 · Dec 31, 2023 | $1.6M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $402.94K |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $2.08M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $606.78K |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $3.37M |
| Revenue | Q3 2025 · Dec 31, 2023 | $1.01M |
| Revenue | Q3 2025 · Dec 31, 2023 | $5.45M |